TransMedics Group, Inc. TMDX investors are continuing to encounter losses from the stock of late. Shares of the Andover, MA-based commercial-stage medical technology company providing organ transplant ...

TransMedics' stock remains under pressure after a weak third quarter, reduced Q4 guidance, the exit of the company's CFO, and ...

TransMedics is facing allegations of fraud, organ trafficking, and unethical practices that have triggered shareholder ...

在其他近期新闻中，TransMedics Group完成了一批飞机的收购，以增强其器官运输能力，使飞机总数达到20架。公司第三季度收入同比增长64%，达到1.088亿美元，主要由美国销售额76%的增长推动。TransMedics修订了2024财年的收入指引，预计在4.28亿美元至4.32亿美元之间。分析师反应不一，Piper ...

总部位于马萨诸塞州、市值21亿美元的医疗技术公司TransMedics Group, Inc.已完成一批旨在增强其器官运输能力的飞机收购。最新增加的是一架从RCS Leasing, LLC购买的固定翼飞机,价格约为1410万美元,使飞机总数达到20架。

NEW YORK CITY, NY / ACCESS Newswire / January 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

Shares of organ transplant innovator TransMedics Group ( TMDX -1.41%) fell 15.7% through Thursday trading, according to data from S&P Global Market Intelligence. TransMedics was the target of an ...

Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of ...

TransMedics Gr TMDX has outperformed the market over the past 5 years by 12.34% on an annualized basis producing an average ...

HB Wealth Management LLC lifted its holdings in shares of TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by 49.2% during the fourth quarter, HoldingsChannel reports. The firm owned 8,149 shares ...

ANDOVER, Mass., Jan. 13, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with ...

Shares of organ transplant innovator TransMedics Group (NASDAQ: TMDX) fell 15.7% through Thursday trading, according to data from S&P Global Market Intelligence. TransMedics was the target of an ...